Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
53,079,424
-
Share change
-
-1,350,731
-
Total reported value
-
$1,853,545,493
-
Price per share
-
$34.92
-
Number of holders
-
168
-
Value change
-
-$47,792,045
-
Number of buys
-
68
-
Number of sells
-
91
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2014
As of 30 Sep 2014,
HAEMONETICS CORP - Common Stock (HAE) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,079,424 shares.
The largest 10 holders included
Neuberger Berman Group LLC, VANGUARD GROUP INC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, BlackRock Fund Advisors, FMR LLC, VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P., WELLINGTON MANAGEMENT CO LLP, Black Creek Investment Management Inc., Van Berkom & Associates Inc., and WESTWOOD HOLDINGS GROUP INC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.